.
To date, 650 kidney transplantations have been performed in the current state of Yugoslavia, out of which 260 (40%) grafts were obtained from cadavers and 390 (60%) from living donors. In addition, 62 kidney transplantations were carried out abroad, namely, 19 (30.7%) from cadavers and 43 (69.3%) from living donors. Analysing the patients with transplanted kidneys, 319 (49.0%) were noted to have some immunological risks: elevated titres of cytotoxic antibodies over 25%, various but compatible blood types, higher indices of lymphocyte stimulation in mixed lymphocyte culture and positive cross-match reactions in 25 cases out of whom 18 (72%) became negative so that kidney transplantation became possible ( Table 2) .
Of non-sensitized patients, 17.6% are on the waiting list in Yugoslavia, in relation to the EDTA register with 48 or 59% of cases in Great Britain. Likewise, highly sensitized patients represent no fewer problems (80-100%), accounting for 23.11% in Yugoslavia, and according to the EDTA register 6.2%; in Great Britain this is only 3% (Table 3 ).
In our country 3604 patients have been treated by some modality of replacement therapy (81% by haemodialysis and 5.5% by peritoneal dialysis). In the EDTA registry countries this was 56 and 9%, respectively. In Yugoslavia 13.5% of the patients received a kidney transplant; this was 35% in the EDTA register (Table 4) .
Besides immunological risk, the course and survival of both patients and grafts are also influenced by donor age, and in our case 138 donors were over 60 years of age. One hundred and twenty-six patients were HBV positive or anti-HCV positive, which may significantly affect the survival both patients and graft after kidney transplantation.
Severe infections are of a special significance, as 57 patients had cytomegalia infection and 102 cases suffered from herpes virus infections, while 38 patients were treated for tuberculosis of various organs.
Malignancy at various localizations, most frequently skin cancer, was found in 38 patients. Cardiovascular complications occurred in 160 patients, and hypertension, controlled with two to Correspondence and offprint requests to: R. Blagojevic-Lazic, Department of Nephrology, University Clinical Center, Pasterova 2, 11000 Belgrade, Yugoslavia. Analysis by years revealed that graft failure occurred in 1.1-6.6% of cases. Functional grafts over 5 years were reported in 58.6% of patients.
In the 1990s, an adequate immunosuppressive therapy was a major problem; therefore, 5-year graft survival was significantly different from 1990 (69.3%) and from 1990 on only 58.6%.
In conclusion, a special problem is the organization of cadaveric transplantation in our country. In our region, there are four to seven cadaveric donors to one million inhabitants, significantly lower compared to some European countries, especially Spain, which has 37 cadaveric donors to one million population. The foundation of Balkan Transplant and its incorporation into Eurotransplant will in our opinion, contribute to a more efficient organization of cadaveric transplantation.
